BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 33360966)

  • 1. Psychiatric genetic counseling for serious mental illness: Impact on psychopathology and psychotropic medication adherence.
    Morris E; Batallones R; Ryan J; Slomp C; Carrion P; Albert A; Austin J
    Psychiatry Res; 2021 Feb; 296():113663. PubMed ID: 33360966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using a pharmacy-based intervention to improve antipsychotic adherence among patients with serious mental illness.
    Valenstein M; Kavanagh J; Lee T; Reilly P; Dalack GW; Grabowski J; Smelson D; Ronis DL; Ganoczy D; Woltmann E; Metreger T; Wolschon P; Jensen A; Poddig B; Blow FC
    Schizophr Bull; 2011 Jul; 37(4):727-36. PubMed ID: 19933540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medication preferences and adherence among individuals with severe mental illness and psychiatric advance directives.
    Wilder CM; Elbogen EB; Moser LL; Swanson JW; Swartz MS
    Psychiatr Serv; 2010 Apr; 61(4):380-5. PubMed ID: 20360277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Brief Adherence Rating Scale (BARS) validated against electronic monitoring in assessing the antipsychotic medication adherence of outpatients with schizophrenia and schizoaffective disorder.
    Byerly MJ; Nakonezny PA; Rush AJ
    Schizophr Res; 2008 Mar; 100(1-3):60-9. PubMed ID: 18255269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methodological challenges in psychiatric treatment adherence research.
    Velligan D; Sajatovic M; Valenstein M; Riley WT; Safren S; Lewis-Fernandez R; Weiden P; Ogedegbe G; Jamison J
    Clin Schizophr Relat Psychoses; 2010 Apr; 4(1):74-91. PubMed ID: 20643631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing medication attitudes and reasons for medication nonadherence among three disparate groups of individuals with serious mental illness.
    Levin JB; Seifi N; Cassidy KA; Tatsuoka C; Sams J; Akagi KK; Sajatovic M
    J Nerv Ment Dis; 2014 Nov; 202(11):769-73. PubMed ID: 25357252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of mental illness and criminality self-stigmas and racial self-concept on outcomes in a forensic psychiatric sample.
    West ML; Vayshenker B; Rotter M; Yanos PT
    Psychiatr Rehabil J; 2015 Jun; 38(2):150-157. PubMed ID: 25938621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The course and outcome of psychiatric illness in people with Prader-Willi syndrome: implications for management and treatment.
    Soni S; Whittington J; Holland AJ; Webb T; Maina E; Boer H; Clarke D
    J Intellect Disabil Res; 2007 Jan; 51(Pt 1):32-42. PubMed ID: 17181601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patients with schizophrenia in Morocco during the COVID-19 pandemic: a longitudinal observational study.
    Doufik J; Lahlou L; al'Absi M; Benhamida J; Laaraj H; Ouhamou M; El Oumary O; Salehddine Z; Mouhadi K; Rammouz I
    East Asian Arch Psychiatry; 2024 Mar; 34(1):3-8. PubMed ID: 38955777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of psychotropic medication adherence among HIV+ individuals living with bipolar disorder.
    Casaletto KB; Kwan S; Montoya JL; Obermeit LC; Gouaux B; Poquette A; Heaton RK; Atkinson JH; Moore DJ;
    Int J Psychiatry Med; 2016; 51(1):69-83. PubMed ID: 26681237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Why and how people decide to stop taking prescribed psychiatric medication: exploring the subjective process of choice.
    Roe D; Goldblatt H; Baloush-Klienman V; Swarbrick M; Davidson L
    Psychiatr Rehabil J; 2009; 33(1):38-46. PubMed ID: 19592378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of insight with medication adherence and the impact on outcomes in patients with schizophrenia and bipolar disorder: results from a 1-year European outpatient observational study.
    Novick D; Montgomery W; Treuer T; Aguado J; Kraemer S; Haro JM
    BMC Psychiatry; 2015 Aug; 15():189. PubMed ID: 26239486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychotropic medication non-adherence and its associated factors among patients with major psychiatric disorders: a systematic review and meta-analysis.
    Semahegn A; Torpey K; Manu A; Assefa N; Tesfaye G; Ankomah A
    Syst Rev; 2020 Jan; 9(1):17. PubMed ID: 31948489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interventions to Improve Pharmacological Adherence Among Adults With Psychotic Spectrum Disorders and Bipolar Disorder: A Systematic Review.
    Hartung D; Low A; Jindai K; Mansoor D; Judge M; Mendelson A; Kansagara D; Motu Apuaka M; Freeman M; Kondo K
    Psychosomatics; 2017; 58(2):101-112. PubMed ID: 28139249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness.
    Velligan DI; Weiden PJ; Sajatovic M; Scott J; Carpenter D; Ross R; Docherty JP;
    J Clin Psychiatry; 2009; 70 Suppl 4():1-46; quiz 47-8. PubMed ID: 19686636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation study of the Medication Adherence Rating Scale. Results from the FACE-SZ national dataset.
    Fond G; Boyer L; Boucekine M; Aden LA; Schürhoff F; Tessier A; Andrianarisoa M; Berna F; Brunel L; Capdevielle D; Chereau I; Mallet J; Denizot H; Dorey JM; Dubertret C; Dubreucq J; Faget C; Gabayet F; Rey R; Richieri R; Passerieux C; Schandrin A; Urbach M; Vidailhet P; Llorca PM; Misdrahi D;
    Schizophr Res; 2017 Apr; 182():84-89. PubMed ID: 27789187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Encouraging patients to take medication as prescribed. Two recent reviews offer advice about assessing and improving treatment adherence.
    Harv Ment Health Lett; 2010 Jan; 26(7):4-5. PubMed ID: 20213933
    [No Abstract]   [Full Text] [Related]  

  • 18. Association of Hydroxylmethyl Glutaryl Coenzyme A Reductase Inhibitors, L-Type Calcium Channel Antagonists, and Biguanides With Rates of Psychiatric Hospitalization and Self-Harm in Individuals With Serious Mental Illness.
    Hayes JF; Lundin A; Wicks S; Lewis G; Wong ICK; Osborn DPJ; Dalman C
    JAMA Psychiatry; 2019 Apr; 76(4):382-390. PubMed ID: 30624557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adherence to antipsychotic drug treatment in early-episode schizophrenia: a six-month naturalistic follow-up study.
    Baloush-Kleinman V; Levine SZ; Roe D; Shnitt D; Weizman A; Poyurovsky M
    Schizophr Res; 2011 Aug; 130(1-3):176-81. PubMed ID: 21636254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationships between insight and medication adherence in outpatients with schizophrenia and bipolar disorder: prospective study.
    Yen CF; Chen CS; Ko CH; Yeh ML; Yang SJ; Yen JY; Huang CF; Wu CC
    Psychiatry Clin Neurosci; 2005 Aug; 59(4):403-9. PubMed ID: 16048445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.